Search Within

Sujana Movva

Formats
  1. Meeting Abstract (26)
  2. Journal Article (21)
  3. Correspondence (1)
Groups
  1. Department of Medicine (48)
  2. Sarcoma Service (48)
  3. Solid Tumor Oncology Division (48)
  4. GSK Faculty (38)
  5. Tow Center for Developmental Oncology (TCDO) (38)
  6. Hematologic Malignancies, Division of (36)

More Groups

People
  1. Ciara Kelly (38)
  2. Sandra D'Angelo (36)
  3. William Tap (36)
  4. Mark Dickson (35)
  5. Mary Keohan (35)
  6. Ping Chi (35)

More People

Years
  1. 2025 (2)
  2. 2024 (13)
  3. 2023 (9)
  4. 2022 (14)
  5. 2021 (2)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Clinical Cancer Research (11)
  3. Annals of Oncology (5)
  4. JCO Precision Oncology (2)
  5. Journal for ImmunoTherapy of Cancer (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (12)
  3. Oxford University Press (6)
  4. Biomed Central Ltd (2)
  5. Nature Publishing Group (2)
  6. American Medical Association (1)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Developing novel genomic risk stratification models in soft tissue and uterine leiomyosarcoma
    Journal Article

    Dermawan, J. K.; Chiang, S.; Singer, S.; Jadeja, B.; Hensley, M. L.; Tap, W. D.; Movva, S.; Maki, R. G.; Antonescu, C. R.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Evaluation of early dexrazoxane use and cardiotoxicity risk in patients with soft tissue sarcoma treated with anthracyclines
    Meeting Abstract

    Jang, K.; Wallins, J. S.; Movva, S.; Tsay, A.; Liu, J. E.; Yu, A. F.
    Journal of the American College of Cardiology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Analysis of survival data with nonproportional hazards: A comparison of propensity-score-weighted methods
    Journal Article

    Handorf, E. A.; Smaldone, M. C.; Movva, S.; Mitra, N.
    Biometrical Journal (2024)

    Fulltext@MSK | Save
  • SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL) and leiomyosarcoma (LMS)
    Journal Article

    Movva, S.; Matloob, S.; Handorf, E. A.; Choy, E.; Merriam, P.; Flieder, D. B.; Cai, K. Q.; Zhou, Y.; Tetzlaff, E. D.; Pagan, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma
    Meeting Abstract

    Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2 study of alrizomadlin, a novel MDM2/p53 inhibitor, in combination with pembrolizumab for treatment of patients with malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    Somaiah, N.; Van Tine, B. A.; Chmielowski, B.; Drabick, J. J.; Chawla, S. P.; McKean, M.; Spira, A. I.; O'Byrne, K. J.; Foresto, S. A.; Movva, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save